Risiko
Årlig pris
0,25%
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
SFDR bærekraftsmål
Artikkel 6
Morningstar-globus
🌐
🌐
🌐
🌐
🌐
Karbonrisiko
Lav
10 største eierandeler
Eli Lilly and Co
11,9%
Johnson & Johnson
8,5%
AbbVie Inc
7,7%
UnitedHealth Group Inc
6,3%
Abbott Laboratories
4,6%
Merck & Co Inc
4,1%
Thermo Fisher Scientific Inc
3,6%
Intuitive Surgical Inc
3,2%
Boston Scientific Corp
3,0%
Amgen Inc
3,0%
Helse
100,0%
Nord-Amerika
100,0%
Med rebalansering
Uten rebalansering
Aksjesparekonto
Bedriftskonto
IPS
Pensjon
Dette koster fondet årlig
Aksjesparekonto:
0,35%
IPS:
0,25%
Pensjon:
0,25%
Prisdetaljer
Pris for fondet:
0,15%
Plattformavgift:
0,10%
(Eventuell rebalansering:
0,10%)
Vis priser med rabatt for Akademikerne Pluss eller Tekna
Avkastning pr. 16.09
Siste måned:
−3,1%
Siste 6 måneder:
−12,5%
Hittil i år:
−13,3%
Siste år:
−18,5%
Siste 3 år (per år):
2,4%
Siste 5 år (per år):
8,2%
Morningstar-rating:
4
ISIN:
IE00B43HR379
Forvaltningskapital:
22 945 083 263 kr
Kategori:
Bransjefond, Helsevern
NAV/Kurs (16.09.2025):
106 kr
Aksjer:
99,9%
Kontanter:
0,1%
Obligasjoner:
0,0%
Annet:
0,0%
Startdato:
20.11.2015